2m 2m 2m 2m 2m 2m 2m
PRIME MEDICINE (PRME)
NASDAQ
$3.55+$0.03 (+0.85%)
Price as of Jul 13, 2026 7:56 PM EDT- $682.7MMarket Cap
- -26.85%1-Year Change
- BiotechnologyIndustry
PRIME MEDICINE (PRME)
$3.55+$0.03 (+0.85%)
PRME | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $3.52 | ||
Change | -$0.26 (-7.01%) | ||
Open | $3.69 | ||
High | $3.69 | ||
Low | $3.50 | ||
Previous Close | $3.78 | ||
Volume | 3,550,485 | ||
30-Day Average Volume | 4,527,038 | ||
1-Week Change | -11.90% | ||
1-Month Change | 26.67% | ||
1-Year Change | -26.85% | ||
3-Year Change | -75.96% | ||
5-Year Change | -82.62% | ||
Fundamentals | |||
Shares Outstanding | 180.6M | ||
Total Assets | $294.7M | ||
Market Cap | $682.7M | ||
Enterprise Value | $618.6M | ||
Period: QTR TTM FY | |||
Revenue | $856,000.00 | ||
Net Income | -$49.1M | ||
Free Cash Flow | -$42.9M | ||
EBIT | -$49.1M | ||
EBITDA | -$47.3M | ||
Net Working Capital | $101.6M | ||
EPS | -$0.28 | ||
Enterprise Value/EBITDA | -13 | ||
Enterprise Value/Revenue | 723 | ||
P/B | 9 | ||
P/E | -14 | ||
PEG | 2 | ||
Price/Free Cash Flow | -16 | ||
Price/Operating Cash Flow | -16 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | 09/10/2019 | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue